Colorectal Cancer Genomics
- Cancer PHGKB -
Last Posted: May 25, 2017
- Dissecting microsatellite instability in colorectal cancer: one size does not fit all
RM Samstein et al, Genome Medicine, May 24, 2017
- Assessing the clinical utility of Wnt pathway markers in colorectal cancer.
Veloudis Georgios et al. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 22(2) 431-436
- Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied Carin R et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 May JCO2016719260
- Advantages and Some Remaining Challenges in Hereditary Gastrointestinal Cancer Panel Testing.
Maga Tara et al. Clinical and translational gastroenterology 2017 May 8(5) e92
- Comparison of the efficiency of colorectal cancer screening programs based on age and genetic risk for reduction of colorectal cancer mortality.
Stanesby Oliver et al. European journal of human genetics : EJHG 2017 May
- Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.
Kastrinos Fay et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 May JCO2016696120
- Differential analysis of mutations in the Jewish population and their implications for diseases.
Einhorn Yaron et al. Genetics research 2017 May 99e3
- Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
Rey Jean-Marc et al. The Journal of molecular diagnostics : JMD 2017 May
- Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.
Frey Melissa K et al. Gynecologic oncology 2017 May
- Universal molecular screening does not effectively detect Lynch syndrome in clinical practice.
Brennan Beatrice et al. Therapeutic advances in gastroenterology 2017 Apr 10(4) 361-371
No hay comentarios:
Publicar un comentario